GW Pharma

Cannabis

Why Approval Of Cannabis-Based Epilepsy Drug May Not Be A Win

Timothy Welty - April 26, 2018

A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two types of epilepsy.

Cannabis

Marijuana-Based Epilepsy Drug Is Close To FDA Approval

Brendan Bures - April 20, 2018

A marijuana-based drug received a unanimous thumbs-up from a panel of experts organized by the Food and Drug Administration.

[td_block_social_counter custom_title=”Follow Us” facebook=”https://www.facebook.com/getfreshtoast/” block_template_id=”td_block_template_2″ f_header_font_size=”eyJhbGwiOiIyMiIsInBvcnRyYWl0IjoiMjEifQ==” f_header_font_line_height=”eyJhbGwiOiIyNnB4IiwicG9ydHJhaXQiOiIyNXB4In0=” f_header_font_weight=”900″ f_header_font_family=”325″ twitter=”https://www.linkedin.com/company/the-fresh-toast” googleplus=”#” instagram=”https://www.instagram.com/getfreshtoast/” manual_count_facebook=”123000″ manual_count_twitter=”6500″ manual_count_instagram=”7000″]

GW Pharma

Latest Articles

Lawsuit Says DEA Acting In Bad Faith Over Marijuana

Can Marijuana Consumers Donate Needed Blood

Be More Productive During The Holidays With Marijuana

It Is The DEA Against The Vast Majority Of The Public About Marijuana

Don't Miss Your Weekly Dose of The Fresh Toast.